Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,030 | -36,951 | -25,060 | -111,637 | -83,149 |
| Depreciation Amortization | 6,386 | 4,474 | 2,184 | 8,649 | 6,465 |
| Accounts receivable | -2,773 | 68 | 26 | -232 | -227 |
| Accounts payable and accrued liabilities | -495 | -444 | -559 | 153 | -187 |
| Other Working Capital | -44,442 | -31,764 | -15,010 | 24,110 | 33,662 |
| Other Operating Activity | 10,663 | 12,019 | 6,955 | 33,204 | 19,526 |
| Operating Cash Flow | $-75,691 | $-52,598 | $-31,464 | $-45,753 | $-23,910 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,913 | -1,527 | -521 | -3,319 | -2,687 |
| Net Acquisitions | 8,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -300 | -250 | -200 | N/A | N/A |
| Other Investing Activity | -300 | -250 | -200 | 0 | 0 |
| Investing Cash Flow | $5,787 | $-1,777 | $-721 | $-3,319 | $-2,687 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 19,805 | 19,810 |
| Common Stock Issued | 2,559 | 2,593 | 741 | 75,180 | 75,175 |
| Financing Cash Flow | $2,559 | $2,593 | $741 | $94,985 | $94,985 |
| Beginning Cash Position | 189,576 | 189,576 | 189,576 | 143,663 | 143,663 |
| End Cash Position | 122,231 | 137,794 | 158,132 | 189,576 | 212,051 |
| Net Cash Flow | $-67,345 | $-51,782 | $-31,444 | $45,913 | $68,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,691 | -52,598 | -31,464 | -45,753 | -23,910 |
| Capital Expenditure | -1,983 | -1,597 | -521 | -3,319 | -2,687 |
| Free Cash Flow | -77,674 | -54,195 | -31,985 | -49,072 | -26,597 |